The Collaboration was Formalized this Week as Part of the Annual ARC SUMMIT 2023 Innovation Conference
ARC, Sheba Medical Center‘s innovation platform, has selected Deloitte Consulting LLP to forge a unique collaboration fueled by a shared vision to help revolutionize and transform health care organizations.
The signing of this agreement “marks a significant turning point, as it paves the way for a shift in the future of health and operating models of health systems in the upcoming decade, propelling them towards transformative change,” said Director General of Sheba Medical Center, Prof. Yitshak Kreiss.
“Deloitte has been working for years to transform the industry into the Future of Health™, a world in which digital medicine, personalized patient care, early engagement before disease, and health and wellness are integrated into daily life. Our research suggests that this model of health can yield more sustainable and equitable systems dramatically extending longevity and reducing health expenditure,” said Asif Dhar, Vice Chair and US Life Sciences and Health Care Leader, Deloitte LLP.
Since its establishment in 2019, the ARC (Accelerate, Redesign, and Collaboration) platform at Sheba Medical Center has emerged as a global leader in driving breakthrough innovation and transforming work processes in hospitals around the world.
This groundbreaking agreement harnesses the power of ARC’s well-established and highly successful model, which has already made significant strides in Israel and numerous centers across the globe. Paired with Deloitte Consulting LLP’s vast experience in Life Science and Health care (LSHC) professional services, this collaboration sets the stage for the widespread implementation of the ARC model in innovation centers worldwide and brings forth a new era of transformative innovation.
Deloitte operates in more than 150 countries and territories, including a vast network of professionals serving the health care industry. In collaboration with ARC, Deloitte Consulting LLP aims to provide comprehensive support to innovation centers and portfolio companies across the globe, offering additional services such as cybersecurity, financial advisory services, tax, and more, built upon Deloitte’s extensive experience in the life sciences and health care sector and deep experience working with a range of clients across the world.
Sheba Medical Center has proudly maintained its strong position as one of the world’s premier hospitals for the past five years, consistently ranking among the top institutions according to Newsweek’s ranking and earning a reputation globally as one of the smartest hospitals capable of effectively harnessing the power of technology and information.
Ilan Birnfeld, Chairman and CEO of Deloitte Israel added, “Beyond being a first-of-its-kind collaboration in Israel, this is significant and momentous news. The combination of Deloitte Consulting LLP’s extensive efforts in Israel and globally, in collaboration with ARC, will serve as fertile ground for the dissemination of Israeli innovation and become a substantial force in helping to shape the future of health care. The world of health care, faces unique challenges in achieving international breakthroughs, requiring established bridges and a deep understanding of diverse health systems while navigating local stakeholders. We firmly believe that the collaboration signed today, led by Gal Ratzkowski, Head of Life Sciences and Health Care sector in Israel, will serve as the vital bridge for this transformative mission. Together, we will work towards realizing the vision of global change in the health care sector.”
Prof. Eyal Zimlichman, Chief Transformation and Innovation Officer at Sheba claimed, “Sheba Medical Center established the ARC innovation platform in order to lead innovation and transformation processes in the world of healthcare on a global scale. Thus far, we have successfully led these processes within Sheba and in various locations around the world, driving economic growth along the way. The partnership between Sheba and Deloitte marks a significant milestone and advances our shared vision for the global healthcare system. We are fully prepared to tackle the complex challenges ahead, energized by the exciting work that awaits us, and firmly believe in our ability to lead the necessary revolution.”